Cargando…
Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease
Alzheimer's disease (AD) is the most prevalent form of dementia. Biomarkers such as levels of amyloid beta (Aβ) in cerebrospinal fluid and ApoE genotyping were suggested for the diagnosis of AD, however, the result is either non-conclusive or with invasive procedure. Genome-wide association stu...
Autores principales: | Ma, Suk Ling, Lam, Linda Chiu Wa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569084/ https://www.ncbi.nlm.nih.gov/pubmed/23429712 http://dx.doi.org/10.9758/cpn.2011.9.2.54 |
Ejemplares similares
-
Biomarkers for Alzheimer’s Disease Early Diagnosis
por: Ausó, Eva, et al.
Publicado: (2020) -
Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
por: Zhang, Ying, et al.
Publicado: (2021) -
Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome
por: Laborde, Carlos M., et al.
Publicado: (2013) -
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
por: Craig-Schapiro, Rebecca, et al.
Publicado: (2011) -
A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer’s Disease Diagnosis Using Targeted Proteomics and Machine Learning
por: Hällqvist, Jenny, et al.
Publicado: (2023)